PRIME hand injury diagnosis system takes hold of innovation prize
[Via Physorg]
medicine posts
You wouldn't expect GPS tech to have an impact on asthma research, but the University of Wisconsin-Madison's David Van Sickle says it will -- he's planning on tagging sufferers so he can learn when and where they reach for their inhalers. The data will hopefully make sorting out environmental triggers of the disease much easier -- it took scientists eight years to prove that soybean dust near the Barcelona harbor caused a massive asthma outbreak in the 80s, a timeline that might have been dramatically shorter if location information had been available from the start. The plan's still in the early stages, but would-be participants can sign up already -- let's just hope the tracker is slightly more attractive than Kogan's enormous watch unit.


Neurosurgery with robotic assistance is getting pretty old hat nowadays, so it looks like scientists are trying to up the difficulty factor by keeping their patients awake -- a team of French doctors just completed the first successful removal of malignant brain tumor from a still-conscious patient, using a computerized laser and an MRI scanner to guide the probe. The fiber-optic laser was fed into the brain through a 3mm (.12 inch) hole in the patient's skull and guided via MRI to the tumor, where it fired for two minutes and completely destroyed the cancerous tissue. Once the tumor cells were dead, the cable was removed and the patient was allowed to return home -- all within a single day. That's pretty impressive, and it comes on the heels of 15 similar trials where five out six patients who underwent the total removal procedure were cancer-free nine months after surgery. The team says further research will cost an additional two million euros to progress, but if this technique works as well as they claim after peer review, we'd guess that money won't be hard to come by.
We may already have spray-on bandages, but Arch Therapeutics has developed a nanostructured substance that they say stops bleeding almost instantly. Originally developed at MIT, the material is awaiting FDA approval and could make its way into operating rooms soon. The liquid is made up of amino acids that form peptides and cluster into long fibers when exposed to salty environments, like, say, a whole bunch of blood. The material isn't terribly new -- it was originally discovered in the 90s, but only recently during an experiment did researchers realize that it would be great for blood control. Shortly thereafter, people saw dollar signs and Arch Therapeutics was founded.







